Net Loss per Share - Antidilutive Securities (Details) - shares |
3 Months Ended | |
|---|---|---|
Mar. 31, 2022 |
Mar. 31, 2021 |
|
| Diluted net loss per share attributable to common stockholders | ||
| Antidilutive securities excluded from computation of of diluted weighted average shares outstanding | 20,616,394 | 18,141,571 |
| Unvested restricted common stock | ||
| Diluted net loss per share attributable to common stockholders | ||
| Antidilutive securities excluded from computation of of diluted weighted average shares outstanding | 1,188,074 | 724,854 |
| Stock options to purchase common stock | ||
| Diluted net loss per share attributable to common stockholders | ||
| Antidilutive securities excluded from computation of of diluted weighted average shares outstanding | 19,428,320 | 17,416,717 |